Dr. Tasker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
8901 Wisconsin Ave
Bethesda, MD 20889Phone+1 301-295-5246Fax+1 301-295-2992- Is this information wrong?
Education & Training
- Naval Medical Center (San Diego)Fellowship, Infectious Disease, 1993 - 1995
- Naval Medical Center (San Diego)Residency, Internal Medicine, 1988 - 1993
- Columbia University Vagelos College of Physicians and SurgeonsClass of 1988
Certifications & Licensure
- CA State Medical License 1991 - 2026
Clinical Trials
- Immune Response Following Seasonal Influenza Vaccination Start of enrollment: 2017 May 08
Publications & Presentations
PubMed
- 69 citationsScalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy.Ying Wang, Chen Yang, Yutong Song, J. Robert Coleman, Marcin Stawowczyk, Juliana Tafrova, Sybil A. Tasker, David A. Boltz, Robert O Baker, Liliana Garcia, Olivia Seale...> ;Proceedings of the National Academy of Sciences of the United States of America. 2021 Jul 20
- 11 citationsSafety and Immunogenicity of a Novel Intranasal Influenza Vaccine (NasoVAX): A Phase 2 Randomized, Controlled Trial.Sybil A. Tasker, Anna Wight O’Rourke, Anvar Suyundikov, Peta-Gay Jackson Booth, Stephan Bart, Vyjayanthi Krishnan, Jianfeng Zhang, Katie J. Anderson, Bertrand Georges,...> ;Vaccines. 2021 Mar 5
- 37 citationsA codon-pair deoptimized live-attenuated vaccine against respiratory syncytial virus is immunogenic and efficacious in non-human primates.Steffen Mueller, Charles B. Stauft, Raj Kalkeri, Fusataka Koidei, Anna Kushnir, Sybil A. Tasker, J. Robert Coleman> ;Vaccine. 2020 Mar 23
- Join now to see all
Press Mentions
- Codagenix Receives FDA Clearance of Investigational New Drug Application for Live-Attenuated, Intranasal RSV Vaccine Candidate CodaVax™-RSVJune 1st, 2022
- Chutes & Ladders—Garraway Will Take over as Roche's Next CMOAugust 23rd, 2019
- Altimmune Submits Investigational New Drug Application for NasoShield in Preparation for Its Phase 1 TrialDecember 11th, 2017
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: